We are excited to announce that the addition of Mr. Pål Falck and Mr. Harry J. Rodriguez to our Advisory Board. Pål and Harry adds a wealth of value-adding competence to guide the company’s strategies to reach its goals.
About Harry J Rodriguez
Harry is a respected strategy-driven international finance professional with a successful track record in navigating uncertainty, identifying opportunities, and implementing effective strategies and controls in Developed and Emerging markets. He has over 30 years of leadership and C-Suite level experience in banking, risk management, and lending covering the United States, Latin America, Asia, the Caribbean, Europe and Northern Africa.
Harry has a Mechanical Engineering Degree from Rensselaer Polytechnic Institute (New York) and a Master of Business Administration from the Simon Business School at the University of Rochester (New York).
About Pål Falck
Pål Falck has a MBA, PhD in Clinical Nephrology focused on Pharmacokinetics. Pål Falck has a broad background within the life science sector including Nordic Medical Director in Oncology & Infections at AstraZeneca, Medical Advisor and Business Development at Pfizer Norway, Healthcare Equity Research Analyst at Arctic Securities in Norway. Pål is the Chief Business Officer at Oncorena AB and a Board Member of University of Oslo, Department of Pharmacy.
